Crushed Posaconazole Delayed-Release Tablets Via Enteral Feeding Tubes: A Cautionary Tale
Ann Pharmacother. 2024 Apr 30:10600280241249705. doi: 10.1177/10600280241249705. Online ahead of print.NO ABSTRACTPMID:38686669 | DOI:10.1177/10600280241249705 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 30, 2024 Category: Drugs & Pharmacology Authors: Nicholas Kane Rachel Rikard Katie McCrory Ashley Marx Source Type: research
Crushed Posaconazole Delayed-Release Tablets Via Enteral Feeding Tubes: A Cautionary Tale
Ann Pharmacother. 2024 Apr 30:10600280241249705. doi: 10.1177/10600280241249705. Online ahead of print.NO ABSTRACTPMID:38686669 | DOI:10.1177/10600280241249705 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 30, 2024 Category: Drugs & Pharmacology Authors: Nicholas Kane Rachel Rikard Katie McCrory Ashley Marx Source Type: research
Temporarily Reversing Warfarin With Low-Dose 4-Factor Prothrombin Complex Concentrate in Left Ventricular Assist Device Patients Undergoing an Invasive Procedure
CONCLUSIONS AND RELEVANCE: Low-dose PCC4 appears to be a safe and effective temporary reversal strategy for patients with LVADs undergoing low-bleed risk elective procedures.PMID:38678311 | DOI:10.1177/10600280241248172 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 28, 2024 Category: Drugs & Pharmacology Authors: Byron Stevenson A Joshua Roberts William E Dager Source Type: research
Temporarily Reversing Warfarin With Low-Dose 4-Factor Prothrombin Complex Concentrate in Left Ventricular Assist Device Patients Undergoing an Invasive Procedure
CONCLUSIONS AND RELEVANCE: Low-dose PCC4 appears to be a safe and effective temporary reversal strategy for patients with LVADs undergoing low-bleed risk elective procedures.PMID:38678311 | DOI:10.1177/10600280241248172 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 28, 2024 Category: Drugs & Pharmacology Authors: Byron Stevenson A Joshua Roberts William E Dager Source Type: research
Transdermal Opioids and the Quality of Life of the Cancer Patient: A Systematic Literature Review
CONCLUSIONS: Transdermal therapy was suggested to have several advantages over oral opioid therapy in enhancing cancer patients' QoL. These benefits span various dimensions, including pain management, physical functioning, mental health, vitality, overall patient improvement, anger/aversion, strength/activity, general QoL, cognitive and emotional functions, fatigue, and insomnia.PMID:38659244 | DOI:10.1177/10600280241247363 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 25, 2024 Category: Drugs & Pharmacology Authors: Patricia Santos Reis Durval Campos Kraychete Emilie de Magalh ães Pedreira Eduardo Silva Reis Barreto C ésar Romero Antunes Júnior Vinicius Borges Alencar Anna Karla do Nascimento Souza Liliane Elze Falc ão Lins-Kusterer Liana Maria Torres de Araujo A Source Type: research
Transdermal Opioids and the Quality of Life of the Cancer Patient: A Systematic Literature Review
CONCLUSIONS: Transdermal therapy was suggested to have several advantages over oral opioid therapy in enhancing cancer patients' QoL. These benefits span various dimensions, including pain management, physical functioning, mental health, vitality, overall patient improvement, anger/aversion, strength/activity, general QoL, cognitive and emotional functions, fatigue, and insomnia.PMID:38659244 | DOI:10.1177/10600280241247363 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 25, 2024 Category: Drugs & Pharmacology Authors: Patricia Santos Reis Durval Campos Kraychete Emilie de Magalh ães Pedreira Eduardo Silva Reis Barreto C ésar Romero Antunes Júnior Vinicius Borges Alencar Anna Karla do Nascimento Souza Liliane Elze Falc ão Lins-Kusterer Liana Maria Torres de Araujo A Source Type: research
Transdermal Opioids and the Quality of Life of the Cancer Patient: A Systematic Literature Review
CONCLUSIONS: Transdermal therapy was suggested to have several advantages over oral opioid therapy in enhancing cancer patients' QoL. These benefits span various dimensions, including pain management, physical functioning, mental health, vitality, overall patient improvement, anger/aversion, strength/activity, general QoL, cognitive and emotional functions, fatigue, and insomnia.PMID:38659244 | DOI:10.1177/10600280241247363 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 25, 2024 Category: Drugs & Pharmacology Authors: Patricia Santos Reis Durval Campos Kraychete Emilie de Magalh ães Pedreira Eduardo Silva Reis Barreto C ésar Romero Antunes Júnior Vinicius Borges Alencar Anna Karla do Nascimento Souza Liliane Elze Falc ão Lins-Kusterer Liana Maria Torres de Araujo A Source Type: research
Transdermal Opioids and the Quality of Life of the Cancer Patient: A Systematic Literature Review
CONCLUSIONS: Transdermal therapy was suggested to have several advantages over oral opioid therapy in enhancing cancer patients' QoL. These benefits span various dimensions, including pain management, physical functioning, mental health, vitality, overall patient improvement, anger/aversion, strength/activity, general QoL, cognitive and emotional functions, fatigue, and insomnia.PMID:38659244 | DOI:10.1177/10600280241247363 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 25, 2024 Category: Drugs & Pharmacology Authors: Patricia Santos Reis Durval Campos Kraychete Emilie de Magalh ães Pedreira Eduardo Silva Reis Barreto C ésar Romero Antunes Júnior Vinicius Borges Alencar Anna Karla do Nascimento Souza Liliane Elze Falc ão Lins-Kusterer Liana Maria Torres de Araujo A Source Type: research
Nirsevimab: Expansion of Respiratory Syncytial Virus Prevention Options in Neonates, Infants, and At-Risk Young Children
CONCLUSIONS: Nirsevimab demonstrated clinical efficacy in reducing RSV-associated MA-LRTI and RSV-associated hospitalizations in infants and was well tolerated.PMID:38654469 | DOI:10.1177/10600280241243357 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 24, 2024 Category: Drugs & Pharmacology Authors: J Hunter Fly Lea S Eiland Jeremy S Stultz Source Type: research
Daprodustat: A Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia of Chronic Kidney Disease
CONCLUSIONS: Daprodustat is a novel oral, non-iron therapy for treatment of anemia of CKD. It was Food and Drug Administration approved in 2023 in patients already receiving dialysis for at least 4 months but not in non-dialysis patients. Long-term data for safety and additional benefits are pending.PMID:38616529 | DOI:10.1177/10600280241241563 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 15, 2024 Category: Drugs & Pharmacology Authors: Haley N Johnson Lalita Prasad-Reddy Source Type: research
Abbreviated Urine Collection Compared With 24-Hour Urine Collection for Measuring Creatinine Clearance in Adult Critically Ill Patients: A Systematic Review
CONCLUSIONS: Abbreviated urine collection may overestimate CrCl compared with 24-hour urine collection. Larger, well-conducted studies are needed to evaluate the accuracy of CrCl measured using different durations of urine collection in critically ill patients.PMID:38619016 | DOI:10.1177/10600280241241820 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 15, 2024 Category: Drugs & Pharmacology Authors: Mohamed Omar Saad Adham Mohamed Mohamed Izham Mohamed Ibrahim Source Type: research
Daprodustat: A Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia of Chronic Kidney Disease
CONCLUSIONS: Daprodustat is a novel oral, non-iron therapy for treatment of anemia of CKD. It was Food and Drug Administration approved in 2023 in patients already receiving dialysis for at least 4 months but not in non-dialysis patients. Long-term data for safety and additional benefits are pending.PMID:38616529 | DOI:10.1177/10600280241241563 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 15, 2024 Category: Drugs & Pharmacology Authors: Haley N Johnson Lalita Prasad-Reddy Source Type: research
Abbreviated Urine Collection Compared With 24-Hour Urine Collection for Measuring Creatinine Clearance in Adult Critically Ill Patients: A Systematic Review
CONCLUSIONS: Abbreviated urine collection may overestimate CrCl compared with 24-hour urine collection. Larger, well-conducted studies are needed to evaluate the accuracy of CrCl measured using different durations of urine collection in critically ill patients.PMID:38619016 | DOI:10.1177/10600280241241820 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 15, 2024 Category: Drugs & Pharmacology Authors: Mohamed Omar Saad Adham Mohamed Mohamed Izham Mohamed Ibrahim Source Type: research
Daprodustat: A Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia of Chronic Kidney Disease
CONCLUSIONS: Daprodustat is a novel oral, non-iron therapy for treatment of anemia of CKD. It was Food and Drug Administration approved in 2023 in patients already receiving dialysis for at least 4 months but not in non-dialysis patients. Long-term data for safety and additional benefits are pending.PMID:38616529 | DOI:10.1177/10600280241241563 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 15, 2024 Category: Drugs & Pharmacology Authors: Haley N Johnson Lalita Prasad-Reddy Source Type: research
Abbreviated Urine Collection Compared With 24-Hour Urine Collection for Measuring Creatinine Clearance in Adult Critically Ill Patients: A Systematic Review
CONCLUSIONS: Abbreviated urine collection may overestimate CrCl compared with 24-hour urine collection. Larger, well-conducted studies are needed to evaluate the accuracy of CrCl measured using different durations of urine collection in critically ill patients.PMID:38619016 | DOI:10.1177/10600280241241820 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - April 15, 2024 Category: Drugs & Pharmacology Authors: Mohamed Omar Saad Adham Mohamed Mohamed Izham Mohamed Ibrahim Source Type: research
